Retina
64
177-192 of 337
- CME/CE Broadcast Replay
Reaching Those At Risk: A Look at Socioeconomics and Retinal Care
1.00 credit - CME/CE Broadcast Replay
Diabetic Eye Disease Pipeline Therapies Part 3: Brolucizumab & PDS
0.50 credits



















































































